Open AccessMaintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation
Author(s) -
Radboud J. Duintjer Tebbens,
Lee M. Hampton,
Steven G.F. Wassilak,
Mark A. Pallansch,
Stephen L. Cochi,
Kimberly M. Thompson
Publication year - 2016
Publication title -
journal of vaccines and vaccination
Language(s) - English
Resource type - Journals
ISSN - 2157-7560
DOI - 10.4172/2157-7560.1000340
Subject(s) - poliovirus , medicine , population , inactivated poliovirus vaccine , poliomyelitis , herd immunity , serotype , immunity , outbreak , transmission (telecommunications) , virology , poliomyelitis eradication , environmental health , immunology , virus , immune system , electrical engineering , engineering
To examine the impact of different bivalent oral poliovirus vaccine (bOPV) supplemental immunization activity (SIA) strategies on population immunity to serotype 1 and 3 poliovirus transmission and circulating vaccine-derived poliovirus (cVDPV) risks before and after globally-coordinated cessation of serotype 1 and 3 oral poliovirus vaccine (OPV13 cessation).